Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @FulcrumTx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FulcrumTx
-
#RareDiseaseDay is February 29. This year, community leaders and our team members shared how they hope to reframe rare for the future. Stay tuned this month for their answers. How do YOU hope to#reframerare?pic.twitter.com/IIfz0NC9NQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our SVP and Head of Clinical Development, Dr. Diego Cadavid recently discussed the genetic factors behind
#FSHD and the progression of its symptoms in an interview with@CheckRare See the full interview here: http://ow.ly/ZTUC50ycneN#raredisease#FSHDAwarenessHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK the global incidence of#sicklecell is estimated to be approximately 300,000 births each year.#sicklecellawareness#invisibleillness http://ow.ly/E3Rl50ya7fs pic.twitter.com/HMN5VneGpx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce that losmapimod has been granted Orphan Drug Designation in
#FSHD by the FDA and we have expanded our patent portfolio. Learn more about this news:http://ow.ly/WVXv50y8h9DHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to stay connected to the latest happenings at Fulcrum? Follow us on
#Instagram! http://ow.ly/iTUa50y819q pic.twitter.com/V6ev3zhHgr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FSHD patient champion Chris Stenmon is featured in the@PatriotLedger this week as a Newsmaker for his work to raise awareness for the disease. Read more about him:http://ow.ly/TIJw50y4tjHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK While#sicklecell disease is most prevalent in Africa and the Middle East, an approximated 234,000 individuals in the U.S. and Europe are also affected.#sicklecellawareness http://ow.ly/u6Ak50y45KO pic.twitter.com/afVr8lSIMv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're looking for highly motivated and passionate new team members! Learn more about our open positions here: http://ow.ly/iGNf50y0RTT
#biotechjobsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you know that it's
#NationalBloodDonorMonth? If you are of African ancestry, consider donating your blood this month to those with#sicklecell- they need blood from those of similar ancestry in order to stay healthy! http://bit.ly/2swqGAT pic.twitter.com/4ndvEl1BDX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK Sickle cell disease is caused by a mutation in the HBB gene that gives rise to mutated beta-subunits. Learn how we're working to address the root cause of this disease: http://ow.ly/sNr550xXp4i pic.twitter.com/aL8n92yyDZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Fulcrum team was excited to help raise awareness of
#FSHD at Eliot Intermediate School this fall. Learn more about our visit in the@FSHDSociety's article here:http://ow.ly/wV3L50xUh91Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're excited to be attending this year's
@jpmorgan Healthcare Conference in San Francisco! We're eager to meet with some of the biggest leaders in the healthcare industry.#JPM20 http://ow.ly/eFV550xTXPhHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK Sickle cell disease is reported to shorten patient life expectancy by approximately 20 to 30 years. We're working to change that. Learn about our focus on#sicklecell http://ow.ly/F1kM50xRc3H pic.twitter.com/U8YdcHNqoF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to announce that our clinical development program has been recognized in
@md_today's list of the Top 10 Muscular Dystrophy Stories of 2019. See the whole list here:http://ow.ly/ZLI850xQawLHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Teonna has used her
#sicklecell diagnosis to inspire her work as an advocate for the#SCD community. Learn more about her story on our website.#sicklecellwarrior#invisibleillness http://ow.ly/Uj1C50xPbeo pic.twitter.com/FBm9LA2ysg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re pleased to announce that Katina Dorton has been appointed to our board where she will also serve as chair of the audit committee. Learn more about her experience and what this means for Fulcrum here:http://ow.ly/C0w250xOkjj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FlashbackFriday to our holiday volunteering event at East End House. Our team members were extremely generous with their donations of gifts and time to help those in need. We had a blast!pic.twitter.com/XRbnUfK3wi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy New Year from the Fulcrum family! We are excited for the progress that 2020 has in store! Check out our pipeline for a preview of what's in store.http://ow.ly/oKTH50xJV9r
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re excited to announce a research collaboration with
@AcceleronPharma to identify small molecules designed to modulate genetic pathways associated with an indication in#pulmonarydisease. Learn more about our partnership here:http://ow.ly/oAos50xJV4KHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#HappyHolidays from the Fulcrum family to yours!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.